ORC6作为非小细胞肺癌的有效预后预测剂,与瘤进展密切相关

Letian Chen1, Dongdong Zhang2, Yujuan Chen1

  • 1Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China.

Oncology letters
|January 30, 2024
PubMed
概括

原始识别复合物6 (ORC6) 在非小细胞肺癌 (NSCLC) 中高度表达,与预后不佳相关. 这表明ORC6是NSCLC诊断和治疗的潜在生物标志物.